We tested the hypothesis that the combination of aripiprazole and clozapine would lead to an improvement in this patient group. Methods: Eleven patients with treatment-resistant schizophrenia ...

(RTTNews) - Viatris (VTRS) reported positive top-line results of Phase 3 study in Japan evaluating the safety and efficacy of EFFEXOR in adults with generalized anxiety disorder. The study ...

Treatment with once-daily EFFEXOR ® met primary and all secondary efficacy endpoints in outpatient adults with GAD EFFEXOR ® was generally well tolerated, consistent with its known safety profile ...

(NASDAQ: VTRS), a global healthcare company, today announced positive top-line results of its Phase 3 study (B2411367) in Japan evaluating the safety and efficacy of EFFEXOR ® (venlafaxine ...

Treatment with once-daily EFFEXOR ® met primary and all secondary efficacy endpoints in outpatient adults with GAD EFFEXOR ® was generally well tolerated, consistent with its known safety ...

PITTSBURGH and TOKYO, Oct. 9, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced positive top-line results of its Phase 3 study (B2411367) in Japan ...

PITTSBURGH and TOKYO, Oct. 9, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced positive top-line results of its Phase 3 study (B2411367) in Japan ...